BREAKING
Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 6 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 6 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 6 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 6 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 6 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 6 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 6 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 6 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 6 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 6 hours ago Why Is PLTR Stock Up Today? Technical Rebound Follows Brutal February Selloff 6 hours ago Palantir Technologies Inc. (PLTR) Surges 5.0% — Developing Story 6 hours ago Live Nation Entertainment, inc (LYV) Misses Q4 2025 Earnings Estimates — EPS $0.73 vs $1.49 Expected 6 hours ago GRAIL, Inc (GRAL) Tops Q4 2025 Earnings Estimates — EPS $-2.46 vs $-3.26 Expected 6 hours ago Sensata (ST) Beats Q4 EPS Estimates By 4.6% In Third Consecutive Quarter 6 hours ago Sensata Technologies Holding plc (ST) Tops Q4 2025 Earnings Estimates — EPS $0.89 vs $0.85 Expected 6 hours ago Vicor (VICR) Q4 EPS of $0.63 Crushes Estimates by 425%, Revenue Surges 27.8% 6 hours ago Vicor Corporation (VICR) Tops Q4 2025 Earnings Estimates — EPS $0.63 vs $0.12 Expected 6 hours ago Why RingCentral Stock Dropped Despite Beating Earnings Estimates by 5.2% 6 hours ago RingCentral, Inc (RNG) Tops Q4 2025 Earnings Estimates — EPS $1.13 vs $1.07 Expected 6 hours ago
BMY

Bristol-Myers Squibb Company

$BMY NYSE Apr 29, 2021 BMO Q1 2021

Investor Toolbox

Listen to Call

Watch or listen to the earnings call recording.

Open Webcast

Read Transcript

Transcript not yet available.

View Infographic

Infographic not yet available.

Earnings History

View past quarters and earnings trends.

View History

BMY Coverage

Event Bristol-Myers Squibb Company (BMY) U.S. Food and Drug Administration Accepts Bristol Myers Squibb’s New Drug Application for Iberdomide in Patients with Relapsed or Refractory Multiple Myeloma Feb 17, 2026 Event Bristol-Myers Squibb Company (BMY) Sec Form 10K Feb 12, 2026 Event Bristol-Myers Squibb Company (BMY) Sec Form 8K Feb 7, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q2 2025 Earnings Call Transcript Jan 22, 2026 Transcript Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call Transcript Jan 22, 2026 News Bristol Myers Squibb (BMY) Earnings: 3Q25 Key Numbers Oct 30, 2025 News Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers Jul 31, 2025 News Key metrics from Bristol Myers Squibb’s (BMY) Q3 2024 earnings results Oct 31, 2024